No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Haleon reported first-half revenue of 5.60bn on Thursday, up 2.2% on a reported basis and 2.6% organically, with second-quarter organic growth improving to 3.1% as North America strengthened.
Adjusted operating profit rose 8.2% at constant currencies to 1.36bn and the adjusted operating margin increased to 24.3%, while adjusted diluted earnings per share rose 12% to 10.3p.
Oral Health was the strongest category, with second-quarter growth of 6.2%, while emerging markets grew 6.3%.
The consumer healthcare group reiterated its full-year guidance for organic revenue growth of 3% to 5% and high-single-digit adjusted operating profit growth at constant currencies.
"We delivered a good first half performance in what remains a challenging consumer environment, with sequential improvement in Q2 and a more balanced price and volume/mix," said chief executive Brian McNamara.
Haleon also raised its interim dividend 9% to 2.4p and said it had completed 457m of its planned 500m share buyback for 2026.
At 0947 BST, shares in Haleon were down 2.03% at 372p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.